Definition of oxaliplatin sensitivity in patients with advanced colorectal cancer previously treated with oxaliplatin-based therapy

被引:0
|
作者
de Gramont Lesparre, A. H. [1 ,2 ,3 ,4 ]
Chibaudel, B. [1 ,2 ,3 ,4 ]
Bourges, O. [1 ,2 ,3 ,4 ]
Perez-Staub, N. [1 ,2 ,3 ,4 ]
Tournigand, C. [1 ,2 ,3 ,4 ]
Maindrault-Goebel, F. [1 ,2 ,3 ,4 ]
Andre, T. [1 ,2 ,3 ,4 ]
Larsen, A. K. [1 ,2 ,3 ,4 ]
Afchain, P. [1 ,2 ,3 ,4 ]
Louvet, C. [1 ,2 ,3 ,4 ]
机构
[1] Hop St Antoine, F-75571 Paris, France
[2] GERCOR, Multidisciplinary Grp Canc Res, Paris, France
[3] Hop La Pitie Salpetriere, Paris, France
[4] INSERM, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4024
引用
收藏
页数:2
相关论文
共 50 条
  • [1] DEFINITION OF OXALIPLATIN SENSITIVITY IN PATIENTS WITH ADVANCED COLORECTAL CANCER PREVIOUSLY TREATED WITH OXALIPLATIN-BASED THERAPY
    de Gramont, A.
    Chibaudel, B.
    Bourges, O.
    Perez-Staub, N.
    Tournigand, C.
    Maindrault-Goebel, F.
    Andre, T.
    Larsen, A.
    Afchain, P.
    Louvet, C.
    ANNALS OF ONCOLOGY, 2009, 20 : 13 - 13
  • [2] Bevacizumab Plus Irinotecan-Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens
    Yildiz, Ramazan
    Buyukberber, Suleyman
    Uner, Aytug
    Yamac, Deniz
    Coskun, Ugur
    Kaya, Ali Osman
    Ozturk, Banu
    Yaman, Emel
    Benekli, Mustafa
    CANCER INVESTIGATION, 2010, 28 (01) : 33 - 37
  • [3] Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimen
    Yildiz, R.
    Buyukberber, S.
    Uner, A.
    Yamac, D.
    Coskun, U.
    Kaya, A. O.
    Ozturk, B.
    Yaman, E.
    Benelkli, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 143 - 143
  • [4] Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer
    Maindrault-Goebel, F
    Tournigand, C
    André, T
    Carola, E
    Mabro, M
    Artru, P
    Louvet, C
    de Gramont, A
    ANNALS OF ONCOLOGY, 2004, 15 (08) : 1210 - 1214
  • [5] Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Bahrami, Afsane
    Amerizadeh, Forouzan
    Hassanian, Seyed Mahdi
    ShahidSales, Soodabeh
    Khazaei, Majid
    Maftouh, Mina
    Ghayour-Mobarhan, Majid
    Ferns, Gordon A.
    Avan, Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (03) : 2193 - 2201
  • [6] Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy
    Yanshuo Cao
    Qing Chang
    Wenjiang Zhang
    Olga Ornatsky
    David Hedley
    Eric X. Chen
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1195 - 1200
  • [7] Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy
    Cao, Yanshuo
    Chang, Qing
    Zhang, Wenjiang
    Ornatsky, Olga
    Hedley, David
    Chen, Eric X.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (06) : 1195 - 1200
  • [8] Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients
    Imai, Hiroo
    Saijo, Ken
    Komine, Keigo
    Yoshida, Yuya
    Sasaki, Keiju
    Suzuki, Asako
    Ouchi, Kota
    Takahashi, Masahiro
    Takahashi, Shin
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [9] Outcomes in patients (pts) with colorectal cancer (CRC) treated with oxaliplatin-based chemotherapy (OC) following prior oxaliplatin exposure
    Bhadkamkar, Nishin Anil
    Sahin, Ibrahim Halil
    Shen, Yehua
    Hassabo, Hesham Mohamed
    Kee, Bryan K.
    Hassan, Manal
    Garrett, Chris R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [10] Oxaliplatin-based chemotherapy in the management of colorectal cancer
    Capdevila, Jaume
    Elez, Elena
    Peralta, Sergio
    Macarulla, Teresa
    Javier Ramos, Francisco
    Tabernero, Josep
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1223 - 1236